(Date:11/25/2009)...swire/--TwomoreH1N1vaccineclinicshavebeenscheduled...HealthDepartmentannouncedtoday.Theyarebeingoffered...nSterlingHeights. ,, TheDec.3clinicwillbeheldfr...ethimerosol-freeversionoftheinjectablevaccinewillb...ableandnasalsprayimmunizationwillbeoffered.Pregnan...
(Date:11/25/2009)...re/--DanielTouizer,CEOof Ci n e r gyHealth ,...ebenefitprograms,isconcernedthatthelabordepartment...ricansarewithoutafull-timejobandunlikelytohaveheal...inedbytheU-6number,whichhasspikedto17.5%,thehighes..."ThesestatisticsarealarmingasitmeansthatmanyAmeric...
(Date:11/25/2009)...ch and Spanish . , , Researchers from th...iagnosis of certain ocular diseases that are very ...tion and keratitis, by applying an existing optica...een used for this purpose. , Scientists from the...affected by one of these two pathologies, finding ...
(Date:11/25/2009)... French . , , Montreal, November 25, 2009 C...rketplace, thanks to a new partnership between Ges...Cognitive Sensing Inc. (CSI), a privately owned te...which commercializes discoveries from the Universi...CSI have announced the signature of a license agre...
(Date:11/25/2009)... to new drugs for people, researchers say , ...gadienes, natural lipid molecules found in soy, co...n cancer, California researchers have found. ,...rs pointed out that they could help explain why so.... , In the study, Dr. Julie Saba, senior scient...
Breaking Medicine News(10 mins):Health News:Macomb County Health Department Schedules Two More H1N1 Flu Vaccine Clinics Dec. 3 and 5 2Health News:Cinergy Health Commentary on Health Care for the Unemployed 2Health News:Achieve early diagnosis of ocular pathologies such as keratitis and macular degeneration 2Health News:Univalor and Cognitive Sensing Inc. to commercialize 4 University of Montreal discoveries 2Health News:Natural Soy Component May Help Treat Colon Cancer 2...t that Superman is actually Clark Kent. , ...ty in St. Louis has discovered that two vital cell...(Pol IV and V), found only in plants, are actually...ct," said Craig Pikaard, Ph.D., Washington Univers...
...nity for Parents of Children with Disabilities , ...pport community for parents of disabled children, ...enter. Designed to assist parents of children with...rmative content and community support features to ...
...The Procter & Gamble Company,(NYSE: PG ) and...he lawsuit P&G,filed on December 12, 2007 agai...infringement on its Olay Regenerist brands. The pa... certain of P&G,s patent,rights identified in ...
...Uses Intego(TM) PET Infusion System to Compare Tec...., Jan. 6 MEDRAD, Inc., has signed a research agr...mic PET imaging with the MEDRAD Intego(TM) PET Inf...cedures. , (Logo: http://www.newscom.com/cgi-b...
...isease Depend on Plasma Donation , , ANNAPOLIS, M... that typically affects children between the ages ... heart disease in children in the United States ac...places vital missing antibodies in a person,s plas...
...am Guides Patients and Families through Complex He..., N.J. (Vocus) January 6, 2009 -- ITelagen, Inc. ...hcare information technology and support, today a...employers and individuals. The Wellness 360 HAP ...
Other Medicine News:Health News:Biologist finds plant polymerases IV and V are really variants of Polymerase II 2Health News:Biologist finds plant polymerases IV and V are really variants of Polymerase II 3Health News:ChildRC.com Launches The Child Resource Center 2Health News:MEDRAD Sponsors PET Research with University of Zurich 2Health News:MEDRAD Sponsors PET Research with University of Zurich 3Health News:MEDRAD Sponsors PET Research with University of Zurich 4Health News:Kawasaki Disease Treated with Plasma-Derived Therapy 2Health News:ITelagen Develops Customized Health Advocacy System for Wellness 360 2Health News:ITelagen Develops Customized Health Advocacy System for Wellness 360 3Health News:ITelagen Develops Customized Health Advocacy System for Wellness 360 4(Date:11/25/2009)...,Nov.25/PRNewswire/--CempraPharmaceuticalsInc.toda...efexecutiveofficer,willpresentatthePiperJaffray21s...,2009,atTheNewYorkPalaceHotelinNewYorkCity.Dr.Fern...antibioticclinicalprogramsforthetreatmentofdrug-re...harmaceuticals ,, Foundedin2006,CempraPharmace...
(Date:11/25/2009)...landsandJOHANNESBURG,November25/PRNewswire/--,iThe...yannouncedtoday,thattheyhavesignedacollaborativeag..., Pyxis,sworldclasscomputationalchemistryandlead...cedivisiontoprovidemedicinaland,syntheticchemistry...onalclientnetwork.iThembaPharmaceuticalsandPyxisDi...
(Date:11/24/2009)...v.24/PRNewswire-Asia/--ChindexInternational,Inc.,(...canproviderofWestern,healthcareproductsandservices...eCompanywillattendthe21stAnnualPiperJaffray,"Unplu...,atthe,NewYorkPalaceHotel. , Managementiscurr...ber1,2009,andholdone-on-onemeetingsthroughouttheda...
Breaking Medicine Technology:iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2Chindex International to Present at Piper Jaffray Health Care Conference 2YMCA Expands Pioneering Healthier Communities Initiative to Lead Healthy Change in Communities Nationwide 56595 1YMCA Expands Pioneering Healthier Communities Initiative to Lead Healthy Change in Communities Nationwide 56595 2YMCA Expands Pioneering Healthier Communities Initiative to Lead Healthy Change in Communities Nationwide 56595 3YMCA Expands Pioneering Healthier Communities Initiative to Lead Healthy Change in Communities Nationwide 56595 4YMCA Expands Pioneering Healthier Communities Initiative to Lead Healthy Change in Communities Nationwide 56595 5ATU Will Not Support 3A Health Care Plan Without Public Option Members of Congress Who Do Not Fight for It 56593 1ATU Will Not Support 3A Health Care Plan Without Public Option Members of Congress Who Do Not Fight for It 56593 2Study reveals new role of vitamin C in skin protection 56591 1Study reveals new role of vitamin C in skin protection 56591 2...1, 2007 /PRNewswire-FirstCall/ -- Forest,Laborator...ults of,the DIAS-2 (Desmoteplase In Acute Ischemic... Phase III study was designed to,investigate the i...ute ischemic stroke treated with Desmoteplase with...compared to placebo. The primary,efficacy endpoint...
...SS WIRE)--Jun 1, 2007 - Introgen Therapeutics, Inc...cal data with INGN,241, the Company,s novel invest...atients with advanced solid tumors., The data (Abs...ual meeting of the American Society of Gene Therap...induced killing in all treated,tumors, including i...
Other Medicine Technology:Topline Results of Phase III Study in Acute Ischemic Stroke,(Dias-2) Do Not Demonstrate Difference Between Desmoteplase and,Placebo 2Topline Results of Phase III Study in Acute Ischemic Stroke,(Dias-2) Do Not Demonstrate Difference Between Desmoteplase and,Placebo 3Topline Results of Phase III Study in Acute Ischemic Stroke,(Dias-2) Do Not Demonstrate Difference Between Desmoteplase and,Placebo 4Introgen Reports Promising Phase 1/2 Clinical Results With INGN 241,in Patients With Advanced Solid Tumors 2Introgen Reports Promising Phase 1/2 Clinical Results With INGN 241,in Patients With Advanced Solid Tumors 3Clip-On
All New Ultra Pb Series Glasses
...d comfortable eye protection Properly manufacture...ximately 90% of scatter radiation. Our high qualit...nd comfort with minimized weight. Our lenses are m...t all industry standards. Most Pulse Glasses are o...
...d comfortable eye protection Properly manufacture...ximately 90% of scatter radiation. Our high qualit...nd comfort with minimized weight. Our lenses are m...t all industry standards. Most Pulse Glasses are o...
Medicine Products: